Given the excellent safety profile observed in trials, longer protocols appear well-tolerated
Adults with a BMI of 27 kg/m or greater (overweight) who also have at least one weight-related comorbidity, such as high blood pressure, Type 2 diabetes, or high cholesterol
Evidence Limits in BPC-157, TB-500, and Soft Tissue Research Evidence in this area can include cell studies, animal studies, pathway research, formulation testing, stability studies, pharmacokinetic research, sports medicine studies, clinical trials, rehabilitation studies, safety reviews, and patient-reported outcomes
A stable and reproducible human blood-brain barrier model derived from hematopoietic stem cells
It reduces your appetite and cravings for food, especially snacks and foods with high calories
What this means for you Even if Cigna's standard formulary doesn't cover Wegovy, your employer might still choose to cover it